- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Gastroenterology Research and Practice
Volume 2013 (2013), Article ID 803139, 2 pages
High or Nonhigh Doses of Proton Pump Inhibitors for Patients with Peptic Ulcer Bleeding?
1Division of Gastroenterology, Department of Medicine, Buddhist Dalin Tzu Chi General Hospital, No. 2, Min-Sheng Road, Dalin, Chia-Yi 622, Taiwan
2School of Medicine, Buddhist Tzu Chi University, No. 701, Zhongyang Rd., Sec. 3, Hualien 97004, Taiwan
3Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taipei Medical University Hospital, No. 252, Wuxing Street, Taipei 11031, Taiwan
4School of Medicine, Taipei Medical University, Taipei, Taiwan
Received 20 August 2012; Accepted 26 December 2012
Copyright © 2013 Yu-Hsi Hsieh and Hwai-Jeng Lin. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- L. S. Lu, S. C. Lin, C. M. Kuo et al., “A real world report on intravenous high-dose and non-high-dose proton-pump inhibitors therapy in patients with endoscopically treated high-risk peptic ulcer bleeding,” Gastroenterology Research and Practice, vol. 2012, Article ID 858612, 7 pages, 2012.
- A. N. Barkun, M. Bardou, E. J. Kuipers et al., “International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding,” Annals of Internal Medicine, vol. 152, no. 2, pp. 101–113, 2010.
- H. J. Lin, W. C. Lo, F. Y. Lee, C. L. Perng, and G. Y. Tseng, “A prospective randomized comparative trial showing that omeprazole prevents rebleeding in patients with bleeding peptic ulcer after successful endoscopic therapy,” Archives of Internal Medicine, vol. 158, no. 1, pp. 54–58, 1998.
- J. Y. W. Lau, J. J. Y. Sung, K. K. C. Lee et al., “Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers,” The New England Journal of Medicine, vol. 343, no. 5, pp. 310–316, 2000.
- C. H. Wang, M. H. M. Ma, H. C. Chou et al., “High-dose vs non-high-dose proton pump inhibitors after endoscopic treatment in patients with bleeding peptic ulcer: a systematic review and meta-analysis of randomized controlled trials,” Archives of Internal Medicine, vol. 170, no. 9, pp. 751–758, 2010.
- H. J. Lin, “High or low doses of PPIs for patients with peptic ulcer bleeding?” Archives of Internal Medicine, vol. 170, no. 18, pp. 1699–1700, 2010.
- F. W. Green Jr., M. M. Kaplan, L. E. Curtis, and P. H. Levine, “Effect of acid and pepsin on blood coagulation and platelet aggregation. A possible contributor to prolonged gastroduodenal mucosal hemorrhage,” Gastroenterology, vol. 74, no. 1, pp. 38–43, 1978.
- H. J. Lin, W. C. Lo, Y. C. Cheng, and C. L. Perng, “Role of intravenous omeprazole in patients with high-risk peptic ulcer bleeding after successful endoscopic epinephrine injection: a prospective randomized comparative trial,” American Journal of Gastroenterology, vol. 101, no. 3, pp. 500–505, 2006.
- J. Y. W. Lau, J. J. Y. Sung, A. C. W. Chan et al., “Stigmata of hemorrhage in bleeding peptic ulcers: an interobserver agreement study among international experts,” Gastrointestinal Endoscopy, vol. 46, no. 1, pp. 33–36, 1997.